showed PAFAH1B3 upregulation was associated with low recurrence-free survival in breast cancer patients overall, in lymph-node-positive tumors, and in grade 1–3 breast cancer patients (22). This evidence concerns the gene PAFAH1B3 and breast carcinoma.